TP53 and adenocarcinoma: More importantly, we further revealed mucinous adenocarcinoma and other adenocarcinoma were also related to the TP53 mutation, and mutations of TP53 and BRAF were considered as a signature to distinguish pathological types, which greatly complements and refines the previous studies (detailed in Fig. 3).